{
  "metadata": {
    "image": "medical_note_03.jpeg",
    "prompt": "soap_enhanced",
    "promptName": "SOAP Enhanced",
    "model": "deepseek-v3.2",
    "modelName": "DeepSeek V3.2",
    "provider": "openrouter",
    "timestamp": "2026-01-14T08:41:06.448Z",
    "latencyMs": 19204
  },
  "output": {
    "raw_response": "{\n  \"soap_note\": {\n    \"subjective\": {\n      \"chief_complaint\": \"Unknown\",\n      \"hpi\": \"Patient with Systemic Lupus Erythematosus (SLE) and Scleroderma. Insufficient detail on current complaints or symptoms provided in text.\",\n      \"symptoms\": [],\n      \"patient_history\": \"Systemic Lupus Erythematosus (SLE), Scleroderma\"\n    },\n    \"objective\": {\n      \"vitals\": {\n        \"bp\": null,\n        \"hr\": null,\n        \"temp\": null,\n        \"rr\": null,\n        \"weight\": null\n      },\n      \"physical_exam\": {\n        \"findings\": [],\n        \"text_raw\": \"Examination section listed, but no findings were transcribed.\"\n      },\n      \"labs_imaging\": \"Pending results for SGPT, Creatinine, and Urine Routine Microscopy (RM).\"\n    },\n    \"assessment\": {\n      \"primary_diagnosis\": {\n        \"value\": \"Systemic Lupus Erythematosus (SLE) with Scleroderma (Overlap Syndrome)\",\n        \"certainty_degree\": 1.00,\n        \"evidence_text\": \"S.L.E. with Scleroderma\"\n      },\n      \"differential_diagnosis\": []\n    },\n    \"plan\": {\n      \"medications\": [\n        {\n          \"drug\": \"Hydroxychloroquine\",\n          \"dosage\": \"200mg\",\n          \"sig\": \"one tablet daily at night\",\n          \"handwriting_confidence\": .95\n        },\n        {\n          \"drug\": \"Folitrax\",\n          \"dosage\": \"15mg\",\n          \"sig\": \"one tablet once per week (Friday night)\",\n          \"handwriting_confidence\": .95\n        },\n        {\n          \"drug\": \"Folvite\",\n          \"dosage\": \"5mg\",\n          \"sig\": \"one tablet twice per week (Saturdays, Sundays)\",\n          \"handwriting_confidence\": .95\n        },\n        {\n          \"drug\": \"Rablet-D\",\n          \"dosage\": \"Unknown\",\n          \"sig\": \"one tablet daily for 2 months before breakfast\",\n          \"handwriting_confidence\": .85\n        },\n        {\n          \"drug\": \"D-logy\",\n          \"dosage\": \"Unknown\",\n          \"sig\": \"one capsule every month\",\n          \"handwriting_confidence\": .85\n        },\n        {\n          \"drug\": \"Wysolone\",\n          \"dosage\": \"5mg\",\n          \"sig\": \"one tablet once daily\",\n          \"handwriting_confidence\": .95\n        }\n      ],\n      \"procedures_ordered\": [\"SGPT test\", \"Creatinine test\", \"Urine Routine Microscopy (RM)\"],\n      \"patient_instructions\": \"Unknown\"\n    }\n  },\n  \"metadata\": {\n    \"ocr_quality_check\": \"Legible structured list. Text appears to be a formatted medication list and investigation order with little narrative history.\",\n    \"critical_ambiguities\": [\"Chief complaint and history of present illness are absent from the provided text. Dosage for 'Rablet-D' and 'Cap. D-logy' not specified. '2 gram June. 16' at the top is ambiguous.\"]\n  }\n}"
  }
}